Eco Animal Health Group PLC Partnership with Moredun Research Institute (4299R)
July 06 2022 - 1:00AM
UK Regulatory
TIDMEAH
RNS Number : 4299R
Eco Animal Health Group PLC
06 July 2022
6 July 2022
ECO Animal Health Group plc
("ECO", the "Company" or the "ECO Group") (AIM: EAH)
Partnership with Moredun Research Institute - Poultry Red Mite
Vaccine
ECO Animal Health Group plc, a leader in the development,
registration and marketing of pharmaceutical products for global
animal health markets, is pleased to announce that its wholly owned
subsidiary, ECO Animal Health Ltd, has entered into a research
partnership with Moredun Research Institute (MRI), UK. This
research involves an exciting project to develop an effective
first-in-class vaccine solution for the sustainable control of
poultry red mite (PRM). MRI has the necessary tools, expertise, and
experience in working with PRM and in parasite vaccine development.
The vaccine will target functions that are important to PRM
development, viability and fertility. These targets will be
identified by analysing data across the developmental stages of PRM
using a reverse vaccinology approach and then evaluated in a robust
PRM challenge model developed and validated at MRI. ECO Animal
Health Ltd is excited about the potential of this innovation to
help address a significant unmet need and improve animal welfare in
the poultry industry.
Poultry Red mite ( Dermanyssus gallinae) infestation is one of
the emerging and important causes of production losses in laying
hens and has a major impact on animal welfare. Poultry red mites
also serve as vectors for several disease-causing bacteria and
viruses in poultry. Their ubiquitous presence threatens the poultry
industry globally, as there are no effective non-chemical solutions
available for the prevention of PRM infestation in poultry.
Pesticides are currently being used by poultry producers to treat
and therefore limit the losses due to heavy PRM infestation.
However, this comes with associated risks including chemical
residues in eggs and meat and resistance development. Heavy PRM
infestation is reported in the EU and UK and this is expected to
increase as a result of animal husbandry legislation changes,
increased treatment resistance, climate warming, all of which is
hampered by the current lack of a sustainable approach to PRM
control.
Under the terms of the partnership, MRI will execute the
sponsored research project over a period of 36 months. If the
programme is successful, ECO may take the option of developing,
registering and commercialising the vaccine under a worldwide
exclusive license from MRI.
David Hallas, Chief Executive of ECO said : "Once again our
R&D team has successfully concluded an agreement to partner
with a leading research institute, in this case MRI, to develop a
vaccine solution to PRM. If successful, the vaccine has very
significant potential globally and would have substantial animal
health benefits."
Dr Stewart Burgess, Principal Investigator at MRI commented "We
are delighted to have entered this research partnership with ECO
which will enable us to apply our knowledge of PRM and expertise in
developing parasite vaccines to support the global poultry
industry."
The information contained within this announcement is deemed by
the Group to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ("MAR") as it forms part
of United Kingdom domestic law by virtue of the European Union
(Withdrawal) Act 2018. Upon the publication of this announcement
via a Regulatory Information Service ("RIS"), this inside
information is now considered to be in the public domain.
For further information please contact:
ECO Animal Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO) 020 8447 8899
IFC Advisory
Graham Herring
Zach Cohen 020 3934 6630
Singer Capital Markets (Nominated Adviser
& Joint Broker)
Mark Taylor
George Tzimas 020 7496 3000
Investec (Joint Broker)
Gary Clarence
Alex Penney 020 7597 5970
Carlo Spingardi
Peel Hunt LLP (Joint Broker)
Dr Christopher Golden
James Steel 020 7418 8900
Equity Developments
Hannah Crowe
Matt Evans 020 7065 2692
About ECO Animal Health
ECO Animal Health Group plc researches, develops and
commercialises products for livestock. Our business strategy is to
generate shareholder value by achieving the maximum sales potential
from the existing product portfolio whilst investing in Research
and Development ("R&D") for new products, particularly
vaccines, and seeking to in-license new products.
About Moredun Research Institute
Moredun Research Institute conducts internationally recognised
research on the infectious diseases of livestock, caused by
important viruses, bacteria and parasites. It employs 170
scientists, vets and support staff who continue to help find
solutions for major challenges to modern farming such as the
consequences of a changing climate; ensuring safe and sustainable
food and water supplies conserving biodiversity and finding
solutions to infectious disease. Today, many of the veterinary
medicines and vaccines that are routinely used on farm have either
been researched, developed or tested at Moredun. More information:
https://www.moredun.ac.uk/
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCSSIFWIEESESW
(END) Dow Jones Newswires
July 06, 2022 02:00 ET (06:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Sep 2024 to Oct 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Oct 2023 to Oct 2024